Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

Samankaltaisia teoksia

• Dipeptidyl peptidase-1 inhibitors in bronchiectasis
  Tekijä: Emma Johnson, et al.
  Julkaistu: (2025-06-01)
• UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
  Tekijä: T. V. Romanova, et al.
  Julkaistu: (2018-06-01)
• The Potential of some Plant Extracts as Radical Scavengers and Dipeptidyl Peptidase-4 Inhibitors
  Tekijä: Malik et al.
  Julkaistu: (2019-03-01)
• Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
  Tekijä: Perusicova, Jindra, et al.
  Julkaistu: (2011)
• Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
  Tekijä: T. Y. Demidova, et al.
  Julkaistu: (2022-03-01)